Cargando…
Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review
INTRODUCTION AND IMPORTANCE: To describe an unusual case with a primary hepatic neuroendocrine tumour (PHNET) with multiple liver metastases. CASE PRESENTATION: We reported a 65-year-old woman with PHNET with multiple liver metastases. She was highly suspected of having primary liver cancer with mul...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591487/ https://www.ncbi.nlm.nih.gov/pubmed/34784532 http://dx.doi.org/10.1016/j.ijscr.2021.106590 |
_version_ | 1784599246149779456 |
---|---|
author | Yu, Wei-Ming Li, Ri Sun, Bing-Lun Du, Ji-Kang Tuo, Hong-Fang |
author_facet | Yu, Wei-Ming Li, Ri Sun, Bing-Lun Du, Ji-Kang Tuo, Hong-Fang |
author_sort | Yu, Wei-Ming |
collection | PubMed |
description | INTRODUCTION AND IMPORTANCE: To describe an unusual case with a primary hepatic neuroendocrine tumour (PHNET) with multiple liver metastases. CASE PRESENTATION: We reported a 65-year-old woman with PHNET with multiple liver metastases. She was highly suspected of having primary liver cancer with multiple intrahepatic metastases before liver biopsy, but was diagnosed with PHNET with multiple liver metastases after histopathology and immunohistochemistry (IHC) examinations. The patient successfully underwent three times of transcatheter arterial chemoembolization (TACE), and is currently living in a good state without related complications. CLINICAL DISCUSSION: Neuroendocrine tumors (NETs), also known as carcinoids or argyrophilic tumors, are very rare malignant tumors. The liver is the main metastasis site of NETs, but primary hepatic neuroendocrine tumors (PHNETs) are extremely rare. Histopathology and immunohistochemistry (IHC) examinations are still the main methods used for diagnosing NETs. There are no treatment guidelines for PHNETs, and surgical resection is generally the preferred treatment. For PHNET patients who are not suitable for surgery, TACE has been proven to be an effective alternative treatment that can effectively reduce the tumour burden and relieve symptoms, but the current evidence is still limited. CONCLUSION: The clinical diagnosis of PHNET still faces great challenges, imaging examinations often lead to misdiagnosis, and its diagnosis mainly depends on histopathology and immunohistochemical examinations. For PHNET patients who are not suitable for surgery, TACE may be an effective alternative therapy. |
format | Online Article Text |
id | pubmed-8591487 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-85914872021-11-22 Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review Yu, Wei-Ming Li, Ri Sun, Bing-Lun Du, Ji-Kang Tuo, Hong-Fang Int J Surg Case Rep Case Report INTRODUCTION AND IMPORTANCE: To describe an unusual case with a primary hepatic neuroendocrine tumour (PHNET) with multiple liver metastases. CASE PRESENTATION: We reported a 65-year-old woman with PHNET with multiple liver metastases. She was highly suspected of having primary liver cancer with multiple intrahepatic metastases before liver biopsy, but was diagnosed with PHNET with multiple liver metastases after histopathology and immunohistochemistry (IHC) examinations. The patient successfully underwent three times of transcatheter arterial chemoembolization (TACE), and is currently living in a good state without related complications. CLINICAL DISCUSSION: Neuroendocrine tumors (NETs), also known as carcinoids or argyrophilic tumors, are very rare malignant tumors. The liver is the main metastasis site of NETs, but primary hepatic neuroendocrine tumors (PHNETs) are extremely rare. Histopathology and immunohistochemistry (IHC) examinations are still the main methods used for diagnosing NETs. There are no treatment guidelines for PHNETs, and surgical resection is generally the preferred treatment. For PHNET patients who are not suitable for surgery, TACE has been proven to be an effective alternative treatment that can effectively reduce the tumour burden and relieve symptoms, but the current evidence is still limited. CONCLUSION: The clinical diagnosis of PHNET still faces great challenges, imaging examinations often lead to misdiagnosis, and its diagnosis mainly depends on histopathology and immunohistochemical examinations. For PHNET patients who are not suitable for surgery, TACE may be an effective alternative therapy. Elsevier 2021-11-12 /pmc/articles/PMC8591487/ /pubmed/34784532 http://dx.doi.org/10.1016/j.ijscr.2021.106590 Text en © 2021 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Yu, Wei-Ming Li, Ri Sun, Bing-Lun Du, Ji-Kang Tuo, Hong-Fang Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review |
title | Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review |
title_full | Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review |
title_fullStr | Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review |
title_full_unstemmed | Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review |
title_short | Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review |
title_sort | primary hepatic neuroendocrine tumour with multiple liver metastases: a case report with literature review |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591487/ https://www.ncbi.nlm.nih.gov/pubmed/34784532 http://dx.doi.org/10.1016/j.ijscr.2021.106590 |
work_keys_str_mv | AT yuweiming primaryhepaticneuroendocrinetumourwithmultiplelivermetastasesacasereportwithliteraturereview AT liri primaryhepaticneuroendocrinetumourwithmultiplelivermetastasesacasereportwithliteraturereview AT sunbinglun primaryhepaticneuroendocrinetumourwithmultiplelivermetastasesacasereportwithliteraturereview AT dujikang primaryhepaticneuroendocrinetumourwithmultiplelivermetastasesacasereportwithliteraturereview AT tuohongfang primaryhepaticneuroendocrinetumourwithmultiplelivermetastasesacasereportwithliteraturereview |